Analyst Consensus ?
ConsensusBuy43 ratings
Bullish3172.1%
Neutral1125.6%
Bearish12.3%
FN2 Earnings Intelligence
AbbVie Inc. analyst ratings
AbbVie Inc. (ABBV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$263.96Current
$127Low
$214.81Average
$315High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| HSBC | Buy | Buy | Maintain | Sep 10, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 17, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 13, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Aug 11, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 10, 2026 |
| Berenberg | Buy | Buy | Maintain | Aug 6, 2026 |
| Erste Group | Buy | Hold | Upgrade | Aug 5, 2026 |
| Guggenheim | Buy | Buy | Maintain | Aug 4, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 3, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 3, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Aug 3, 2026 |
| William Blair | Buy | Buy | Maintain | Jul 31, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 31, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 15, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 13, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 10, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Feb 17, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Oct 17, 2025 |
| Truist Securities | Buy | Buy | Maintain | Feb 3, 2025 |
| Leerink Partners | Outperform | Market Perform | Upgrade | Nov 22, 2024 |
| Argus Research | Buy | Hold | Upgrade | Nov 4, 2024 |
| Goldman Sachs | Buy | Neutral | Upgrade | Dec 11, 2023 |
| CFRA | Hold | Buy | Downgrade | Mar 29, 2023 |
| SVB Leerink | Market Perform | Underperform | Upgrade | Feb 10, 2023 |
| Atlantic Equities | Neutral | Neutral | Maintain | Feb 10, 2023 |
| Societe Generale | Hold | Buy | Downgrade | Nov 8, 2022 |
| Mizuho | Buy | Buy | Maintain | Feb 4, 2022 |
| Bernstein | Outperform | Outperform | Maintain | Jan 3, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 18, 2020 |
| Citi | Buy | Buy | Maintain | Nov 20, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Sep 4, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jan 3, 2019 |
| Argus | Buy | Buy | Maintain | Nov 6, 2018 |
| PiperJaffray | Neutral | Overweight | Downgrade | Jun 1, 2018 |
| Credit Suisse | Underperform | Neutral | Downgrade | May 30, 2018 |
| Leerink Swann | Market Perform | Outperform | Downgrade | Jan 29, 2018 |
| Jefferies | Buy | Buy | Maintain | Sep 15, 2017 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 17, 2017 |
Named analyst price targets
Upside is calculated against the persisted current price $263.96. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| HSBC | Rajesh Kumar | $315 | $250.98 | +19.3% | Sep 10, 2026 |
| Piper Sandler | Analyst unavailable | $303 | $265.97 | +14.8% | Aug 20, 2026 |
| Wells Fargo | Analyst unavailable | $300 | $249.45 | +13.7% | Aug 17, 2026 |
| Wolfe Research | Alexandria Hammond | $300 | $248.66 | +13.7% | Aug 13, 2026 |
| Guggenheim | Analyst unavailable | $288 | $245.08 | +9.1% | Aug 4, 2026 |
| Morgan Stanley | Analyst unavailable | $296 | $246.26 | +12.1% | Aug 3, 2026 |
| Canaccord Genuity | Gary Nachman | $290 | $250.88 | +9.9% | Aug 3, 2026 |
| Barclays | Analyst unavailable | $300 | $263.48 | +13.7% | Jul 29, 2026 |
| Canaccord Genuity | Analyst unavailable | $282 | $256.15 | +6.8% | Jul 22, 2026 |
| UBS | Analyst unavailable | $260 | $247.05 | -1.5% | Jul 13, 2026 |
| BMO Capital | Analyst unavailable | $300 | $246.69 | +13.7% | Jul 13, 2026 |
| RBC Capital | Trung Huynh | $280 | $246.8 | +6.1% | Jul 10, 2026 |
| Wells Fargo | Analyst unavailable | $295 | $249.91 | +11.8% | Jul 10, 2026 |
| Guggenheim | Analyst unavailable | $261 | $252.61 | -1.1% | Jul 9, 2026 |
| HSBC | Analyst unavailable | $300 | $255.17 | +13.7% | Jul 6, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $265 | $261.07 | +0.4% | Jul 6, 2026 |
| Canaccord Genuity | Analyst unavailable | $273 | $230.06 | +3.4% | Jun 23, 2026 |
| Wells Fargo | Analyst unavailable | $260 | $216.63 | -1.5% | Jun 22, 2026 |
| Evercore ISI | Analyst unavailable | $235 | $212.04 | -11.0% | May 15, 2026 |
| Piper Sandler | Analyst unavailable | $298 | $208.5 | +12.9% | May 14, 2026 |
| Morgan Stanley | Analyst unavailable | $278 | $212.14 | +5.3% | Apr 30, 2026 |
| Piper Sandler | Analyst unavailable | $294 | $200.49 | +11.4% | Apr 23, 2026 |
| Canaccord Genuity | Analyst unavailable | $262 | $203.71 | -0.7% | Apr 20, 2026 |
| Guggenheim | Vamil Divan | $249 | $210.15 | -5.7% | Apr 10, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $240 | $211.59 | -9.1% | Apr 8, 2026 |
| RBC Capital | Trung Huynh | $260 | $228.44 | -1.5% | Feb 24, 2026 |
| Barclays | Analyst unavailable | $275 | $224.35 | +4.2% | Feb 19, 2026 |
| Piper Sandler | Analyst unavailable | $299 | $232.86 | +13.3% | Feb 18, 2026 |
| UBS | Analyst unavailable | $230 | $217.42 | -12.9% | Feb 5, 2026 |
| Evercore ISI | Gavin Clark-Gartner | $228 | $217.02 | -13.6% | Feb 4, 2026 |
| Goldman Sachs | Asad Haider | $223 | $219.77 | -15.5% | Jan 28, 2026 |
| Berenberg Bank | Analyst unavailable | $275 | $214.35 | +4.2% | Jan 20, 2026 |
| BMO Capital | Evan David Seigerman | $258 | $217.74 | -2.3% | Jan 15, 2026 |
| UBS | Analyst unavailable | $240 | $223.93 | -9.1% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $269 | $222.48 | +1.9% | Dec 12, 2025 |
| HSBC | Analyst unavailable | $265 | $222.99 | +0.4% | Dec 10, 2025 |
| Piper Sandler | David Amsellem | $289 | $213.57 | +9.5% | Nov 5, 2025 |
| Raymond James | Gary Nachman | $256 | $218.04 | -3.0% | Nov 3, 2025 |
| Guggenheim | Analyst unavailable | $242 | $229.57 | -8.3% | Oct 20, 2025 |
| Raymond James | Gary Nachman | $250 | $226.87 | -5.3% | Oct 17, 2025 |
| Piper Sandler | Analyst unavailable | $284 | $230.69 | +7.6% | Oct 10, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $250 | $231.24 | -5.3% | Oct 9, 2025 |
| UBS | Analyst unavailable | $251 | $236.56 | -4.9% | Oct 3, 2025 |
| HSBC | Analyst unavailable | $225 | $244.38 | -14.8% | Oct 2, 2025 |
| Cantor Fitzgerald | Carter Gould | $245 | $218.34 | -7.2% | Sep 15, 2025 |
| Raymond James | Gary Nachman | $220 | $190.14 | -16.7% | Feb 3, 2025 |
| BMO Capital | Evan Seigerman | $215 | $190.14 | -18.5% | Feb 3, 2025 |
| BMO Capital | Evan David Seigerman | $208 | $201.61 | -21.2% | Nov 12, 2024 |
| BMO Capital | Evan David Seigerman | $228 | $201.5 | -13.6% | Oct 31, 2024 |
| Bank of America Securities | Charlie Yang | $210 | $201.5 | -20.4% | Oct 31, 2024 |
| Citigroup | Geoff Meacham | $226 | $201.5 | -14.4% | Oct 31, 2024 |
| Bank of America Securities | Geoff Meacham | $195 | $188.57 | -26.1% | Oct 18, 2024 |
| Bernstein | Courtney Breen | $203 | $190.46 | -23.1% | Oct 17, 2024 |
| Raymond James | Christopher Raymond | $209 | $197.35 | -20.8% | Aug 23, 2024 |
| BMO Capital | Evan Seigerman | $214 | $172.01 | -18.9% | Jul 19, 2024 |
| Raymond James | Christopher Raymond | $190 | $171.36 | -28.0% | Jun 18, 2024 |
| HSBC | Rajesh Kumar | $185 | $162.14 | -29.9% | Jun 5, 2024 |
| Deutsche Bank | James Shin | $175 | $156.96 | -33.7% | May 24, 2024 |
| Cantor Fitzgerald | Louise Chen | $200 | $164.35 | -24.2% | May 17, 2024 |
| BMO Capital | Evan Seigerman | $180 | $158.58 | -31.8% | Apr 29, 2024 |
| Barclays | Carter Gould | $195 | $179.79 | -26.1% | Mar 27, 2024 |
| William Blair | Tim Lugo | $190 | $163.91 | -28.0% | Jan 29, 2024 |
| Raymond James | Christopher Raymond | $170 | $142.03 | -35.6% | Nov 9, 2023 |
| Raymond James | Gary Nachman | $177 | $149.12 | -32.9% | Sep 29, 2023 |
| Guggenheim | Vamil Divan | $171 | $147.01 | -35.2% | May 9, 2023 |
| BMO Capital | Analyst unavailable | $167 | $145.49 | -36.7% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $182 | $163.44 | -31.1% | Dec 6, 2022 |
| Credit Suisse | Analyst unavailable | $170 | $152.16 | -35.6% | Nov 18, 2022 |
| Leerink Partners | Analyst unavailable | $135 | $142.72 | -48.9% | Sep 30, 2022 |
| Argus Research | Analyst unavailable | $155 | $137.91 | -41.3% | Aug 24, 2022 |
| Barclays | Analyst unavailable | $160 | $143.51 | -39.4% | Aug 1, 2022 |
| Morgan Stanley | Terence Flynn | $191 | $152.15 | -27.6% | Jul 14, 2022 |
| Leerink Partners | David Risinger | $140 | $148.03 | -47.0% | May 24, 2022 |
| Berenberg Bank | Luisa Hector | $135 | $151.01 | -48.9% | May 22, 2022 |
| Morgan Stanley | Terence Flynn | $188 | $147.87 | -28.8% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $200 | $146.88 | -24.2% | May 2, 2022 |
| BMO Capital | Gary Nachman | $174 | $157.72 | -34.1% | Apr 26, 2022 |
| Barclays | Carter Gould | $174 | $162.31 | -34.1% | Apr 16, 2022 |
| Morgan Stanley | Terence Flynn | $192 | $168.91 | -27.3% | Apr 6, 2022 |
| UBS | Navin Jacob | $147 | $150.56 | -44.3% | Mar 5, 2022 |
| Truist Financial | Robyn Karnauskas | $160 | $144.03 | -39.4% | Feb 21, 2022 |
| Mizuho Securities | Vamil Divan | $166 | $140.65 | -37.1% | Feb 6, 2022 |
| J.P. Morgan | Chris Schott | $180 | $140.73 | -31.8% | Feb 3, 2022 |
| Barclays | Carter Gould | $150 | $140.73 | -43.2% | Feb 3, 2022 |
| Piper Sandler | Christopher Raymond | $160 | $138.62 | -39.4% | Feb 2, 2022 |
| Evercore ISI | Joshua Schimmer | $133 | $137 | -49.6% | Feb 1, 2022 |
| Citigroup | Andrew Baum | $155 | $137.92 | -41.3% | Jan 29, 2022 |
| BMO Capital | Gary Nachman | $153 | $136.78 | -42.0% | Jan 18, 2022 |
| Cowen & Co. | Steve Scala | $150 | $136.78 | -43.2% | Jan 18, 2022 |
| Bernstein | Aaron Gal | $155 | $134.03 | -41.3% | Jan 3, 2022 |
| Wells Fargo | Mohit Bansal | $165 | $120.62 | -37.5% | Dec 8, 2021 |
| Societe Generale | Justin Smith | $172 | $117.66 | -34.8% | Nov 23, 2021 |
| Argus Research | David Toung | $140 | $112.57 | -47.0% | Aug 5, 2021 |
| RBC Capital | Daniel Busby | $135 | $112.9 | -48.9% | Aug 1, 2021 |
| Wolfe Research | Tim Anderson | $127 | $110.91 | -51.9% | May 3, 2021 |
Track every rating change on ABBV the moment it posts. Free to start.
Start freeGet the ABBV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.